Loading clinical trials...

MGTA-145 + Plerixafor in the Mobilization of Hematopoietic Stem Cells for Autologous Transplantation in Multiple Myeloma | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 2NCT04552743

MGTA-145 + Plerixafor in the Mobilization of Hematopoietic Stem Cells for Autologous Transplantation in Multiple Myeloma

This study evaluates a new drug MGTA-145 in combination with plerixafor (Mozobil) to mobilize stem cells into the peripheral blood for collection by apheresis. The stem cells will be used for autologo...

Lead sponsor: Surbhi Sidana, MD•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 1/2

A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)

NCT06953960 · Multiple Myeloma

RECRUITING

Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols

NCT02682667 · Multiple Myeloma, Lymphoma, Non-Hodgkin, and more

RECRUITING

Tissue Collection for Studies of Lymph Cancer

NCT01676805 · Hodgkin Disease, Lymphoma, Non-Hodgkin, and more

RECRUITINGPhase 1

Imaging Study of [89Zr]DFO-YS5 for Detecting CD46 Positive Malignancy in Multiple Myeloma

NCT05892393 · Multiple Myeloma, Plasma Cell Myeloma

RECRUITINGNA

The Ambient Light Multiple Myeloma Study

NCT05737732 · Multiple Myeloma

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 10, 2022Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment25

Start dateOct 2020

Last updatedSep 10, 2022

Condition

Multiple Myeloma

Locations shown

Stanford University

Stanford, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 10, 2022Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions